Cliff Asness's ELDN Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 581,028 shares of Eledon Pharmaceuticals, Inc. (ELDN) worth $2.29 M, representing 0.00% of the portfolio. First purchased in 2025-Q4, this short-term holding has been held for 3 quarters.
Based on 13F filings, Cliff Asness has maintained this position in ELDN for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2026, adding 408,611 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Eledon Pharmaceuticals (ELDN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Eledon Pharmaceuticals (ELDN) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +408,611 | Add 236.99% | 581,028 | $3.94 |
| Q1 2026 | +112,202 | Add 186.34% | 172,417 | $3.08 |
| Q4 2025 | +60,215 | New Buy | 60,215 | $1.51 |
Cliff Asness's Eledon Pharmaceuticals Investment FAQs
Cliff Asness first purchased Eledon Pharmaceuticals, Inc. (ELDN) in Q4 2025, acquiring 60,215 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Eledon Pharmaceuticals, Inc. (ELDN) for 3 quarters since Q4 2025.
Cliff Asness's largest addition to Eledon Pharmaceuticals, Inc. (ELDN) was in Q2 2026, adding 581,028 shares worth $2.29 M.
According to the latest 13F filing for Q2 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 581,028 shares of Eledon Pharmaceuticals, Inc. (ELDN), valued at approximately $2.29 M.
As of the Q2 2026 filing, Eledon Pharmaceuticals, Inc. (ELDN) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Eledon Pharmaceuticals, Inc. (ELDN) was 581,028 shares, as reported at the end of Q2 2026.